You just read:

MAP Pharmaceuticals to Present Additional Data Analyses From LEVADEX™ FREEDOM-301 Trial at 2010 European Headache and Migraine Trust International Congress

News provided by

MAP Pharmaceuticals, Inc.

Oct 20, 2010, 08:00 ET